Rimola Jordi, Sapena Víctor, Brancatelli Giuseppe, Darnell Anna, Forzenigo Laura, Mähringer-Kunz Aline, Paisant Anita, Renzulli Matteo, Schima Wolfgang, Terraz Sylvain, Valls Carlos, Wagner Mathilde, Ayuso Carmen, Vilgrain Valerie, Reig Maria, Ronot Maxime
BCLC Group, Radiology Department, Hospital Clínic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
IDIBAPS, Statistics Core, Barcelona, Spain.
Hepatology. 2022 Nov;76(5):1318-1328. doi: 10.1002/hep.32494. Epub 2022 Jun 8.
BACKGROUND & AIMS: The diagnostic accuracy of Liver Imaging Reporting and Data System (LI-RADS) v.2018 and European Association for the Study of the Liver (EASL) criteria for the diagnosis of HCC have been widely evaluated, but their reliability should be investigated. We aimed to assess and compare the reliability of LI-RADS v.2018 and EASL criteria for the diagnosis of HCC using MRI with extracellular contrast agents (ECAs) and gadoxetic acid (GA) and determine the effect of ancillary features on LI-RADS reliability.
APPROACH & RESULTS: Ten readers reviewed MRI studies of 92 focal liver lesions measuring <3 cm acquired with ECAs and GA <1 month apart from two prospective trials, assessing EASL criteria, LI-RADS major and ancillary features, and LI-RADS categorization with and without including ancillary features. Inter-reader agreement for definite HCC diagnosis was substantial and similar for the two contrasts for both EASL and LI-RADS criteria. For ECA-MRI and GA-MRI, respectively, inter-reader agreement was k = 0.72 (95% CI, 0.63-0.81) and k = 0.72 (95% CI, 0.63-0.80); for nonrim hyperenhancement, k = 0.63 (95% CI, 0.54-0.72) and k = 0.57 (95% CI, 0.48-0.66); and for nonperipheral washout, k = 0.49 (95% CI, 0.40-0.59) and k = 0.48 (95% CI, 0.37-0.58) for enhancing capsule. The inter-reader agreement for LI-RADS after applying ancillary features remained in the same range of agreement.
Agreement for definite HCC was substantial and similar for both scoring systems and the two contrast agents in small focal liver lesions. Agreement for LI-RADS categorization was lower for both contrast agents, and including LI-RADS ancillary features did not improve agreement.
肝脏影像报告和数据系统(LI-RADS)v.2018及欧洲肝脏研究协会(EASL)的肝细胞癌(HCC)诊断标准的诊断准确性已得到广泛评估,但其可靠性仍需研究。我们旨在评估和比较LI-RADS v.2018及EASL标准在使用细胞外造影剂(ECA)和钆塞酸二钠(GA)的MRI诊断HCC中的可靠性,并确定辅助特征对LI-RADS可靠性的影响。
十位阅片者回顾了两项前瞻性试验中92个直径小于3cm的肝脏局灶性病变的MRI研究,这些研究使用ECA和GA在相隔不到1个月的时间内进行,评估EASL标准、LI-RADS主要和辅助特征,以及包含和不包含辅助特征的LI-RADS分类。对于明确的HCC诊断,阅片者间的一致性很高,且对于EASL和LI-RADS标准,两种造影剂的一致性相似。对于ECA-MRI和GA-MRI,阅片者间的一致性分别为k = 0.72(95%CI,0.63 - 0.81)和k = 0.72(95%CI,0.63 - 0.80);对于非边缘性高增强,k = 0.63(95%CI,0.54 - 0.72)和k = 0.57(95%CI,0.48 - 0.66);对于非周边性廓清,k = 0.49(95%CI,0.40 - 0.59)和k = 0.48(95%CI,0.37 - 0.58)用于强化包膜。应用辅助特征后,LI-RADS的阅片者间一致性仍在相同范围内。
对于小的肝脏局灶性病变,两种评分系统和两种造影剂在明确的HCC诊断上一致性很高且相似。两种造影剂在LI-RADS分类上的一致性较低,且纳入LI-RADS辅助特征并未提高一致性。